BioSpecifics (BSTC) Submits BLA for XIAFLEX as Peyronie's Treatment
Tweet Send to a Friend
BioSpecifics Technologies Corp. (NASDAQ: BSTC) announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


